Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune Woan, Frank Cichocki, Bruce R. Blazar et al.|Cell stem cell|2021Cited by 153
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate CancerShee Kwan Phung, Martin Felices, Nicholas A. Zorko et al.|Cancer Immunology Research|2024Cited by 9
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8
Chronic NK cell activation results in a dysfunctional, tissue resident–like state mediated by KLF2 deficiencyJacob A. Myers, Jeffrey S. Miller, Rih‐Sheng Huang et al.|Blood|2025Cited by 4
Effect of camelid B7-H3 tri-specific killer engagers on natural killer cells in patients with prostate cancer.Nicholas A. Zorko, Jeffrey S. Miller, Madison Shackelford et al.|Journal of Clinical Oncology|2024Cited by 1